Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

BIB vs FTXH: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and First Trust Nasdaq Pharmaceuticals ETF

Fund A

vs

Fund B

Holdings overlap

32%

of assets, by weight

Shared positions

37

of 259 / 51 holdings

BIB expense ratio

0.95%

net, per year

FTXH expense ratio

0.60%

net, per year

Shared holdings

Company

BIB

FTXH

G

GILDGILEAD SCIENCES INC

5.19%

3.54%

V

VRTXVERTEX PHARMACEUTICALS INC

5.18%

3.40%

A

AMGNAMGEN INC

4.99%

3.43%

R

REGNREGENERON PHARMACEUTICALS

3.57%

3.74%

B

BIIBBIOGEN INC

1.61%

3.62%

V

VTRSVIATRIS INC

1.05%

3.43%

U

UTHRUNITED THERAPEUTICS CORP

1.36%

3.31%

A

ALNYALNYLAM PHARMACEUTICALS INC

2.24%

0.52%

I

INCYINCYTE CORP

1.08%

2.21%

J

JAZZJAZZ PHARMACEUTICALS PLC

0.81%

2.17%

I

ILMNILLUMINA INC

1.39%

1.55%

E

EXELEXELIXIS INC

0.73%

1.51%

M

MEDPMEDPACE HOLDINGS INC

0.71%

1.42%

P

PTCTPTC THERAPEUTICS INC

0.34%

1.27%

B

BMRNBIOMARIN PHARMACEUTICAL INC

0.62%

1.22%

R

ROIVROIVANT SCIENCES LTD

1.20%

0.50%

N

NBIXNEUROCRINE BIOSCIENCES INC

0.89%

1.19%

H

HALOHALOZYME THERAPEUTICS INC

0.44%

1.11%

M

MRNAMODERNA INC

1.04%

0.49%

A

ALKSALKERMES PLC

0.39%

1.02%

G

GHGUARDANT HEALTH INC

0.95%

0.51%

I

IONSIONIS PHARMACEUTICALS INC

0.71%

0.48%

S

SYRESPYRE THERAPEUTICS INC

0.32%

0.61%

A

ARWRARROWHEAD PHARMACEUTICALS IN

0.61%

0.56%

P

PTGXPROTAGONIST THERAPEUTICS INC

0.36%

0.60%

Only in BIB

?

—N/A

17.83%

I

IQMMPROSHARES GENIUS MNY MKT ETF

7.57%

?

—Repurchase Agreement

3.50%

R

RVMDREVOLUTION MEDICINES INC

1.74%

R

RPRXROYALTY PHARMA PLC- CL A

1.34%

A

ARGXARGENX SE - ADR

1.33%

I

INSMINSMED INC

1.29%

A

AGPXXINVESCO GVT & AGNCY-INST

0.90%

A

ASNDASCENDIS PHARMA A/S

0.77%

S

SMMTSUMMIT THERAPEUTICS INC

0.76%

B

BBIOBRIDGEBIO PHARMA INC

0.72%

A

AXSMAXSOME THERAPEUTICS INC

0.67%

M

MDGLMADRIGAL PHARMACEUTICALS INC

0.64%

B

BNTXBIONTECH SE-ADR

0.61%

S

SNYSANOFI-ADR

0.60%

P

PRAXPRAXIS PRECISION MEDICINES I

0.54%

C

CYTKCYTOKINETICS INC

0.53%

O

ONCBEONE MEDICINES LTD-ADR

0.51%

T

TEMTEMPUS AI INC-CL A

0.49%

A

ABVXABIVAX SA-ADR

0.46%

?

—Nuvalent, Inc.

0.45%

I

IBRXIMMUNITYBIO INC

0.43%

P

PCVXVAXCYTE INC

0.41%

I

IMVTIMMUNOVANT INC

0.38%

R

RYTMRHYTHM PHARMACEUTICALS INC

0.34%

Only in FTXH

J

JNJJOHNSON & JOHNSON

7.45%

B

BMYBRISTOL-MYERS SQUIBB CO

7.36%

M

MRKMERCK & CO. INC.

7.36%

A

ABBVABBVIE INC

7.10%

L

LLYELI LILLY & CO

6.62%

P

PFEPFIZER INC

3.85%

C

CAHCARDINAL HEALTH INC

3.49%

Z

ZTSZOETIS INC

3.41%

C

CRLCHARLES RIVER LABORATORIES

1.26%

E

ELANELANCO ANIMAL HEALTH INC

0.90%

T

TGTXTG THERAPEUTICS INC

0.57%

?

—Catalyst Pharmaceuticals Inc.

0.56%

R

RCUSARCUS BIOSCIENCES INC

0.55%

D

DGCXXBNY DREYFUS GOVERNMENT CASH

0.11%

Hold BIB and FTXH together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

BIB vs IBBQInvesco Nasdaq Biotechnology ETF

BIB vs IBBiShares Biotechnology ETF

FTXH vs FHLCFidelity MSCI Health Care Index ETF

FTXH vs VHTVANGUARD HEALTH CARE INDEX FUND

FTXH vs IBBQInvesco Nasdaq Biotechnology ETF

BIB vs UWMProShares Ultra Russell2000

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.